Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
FUTURE ONCOLOGY
Rivista
Codice:
E193866
ISSN:
1479-6694
Dati Generali
Dati Generali
Pubblicazioni (20)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer
Articolo
CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine
Articolo
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma
Articolo
Dabrafenib-trametinib combination in 'field-practice': An Italian experience
Articolo
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment
Articolo
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Articolo
Fixed-duration ibrutinib-venetoclax for first-line treatment of patients with chronic lymphocytic leukemia: the REALITY-WW prospective real-world study cohort
Articolo
From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
Articolo
How well does acalabrutinib work and how safe is it to treat patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have had previous treatments? a plain language summary of 2 key studies
Articolo
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma
Articolo
Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendations
Articolo
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary
Articolo
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates
Articolo
Nivolumab and its use in the second-line treatment of metastatic urothelial cancer
Articolo
Outcomes of hepatocellular carcinoma patients treated with sorafenib: A meta-analysis of Phase III trials
Articolo
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model
Articolo
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
Articolo
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib
Articolo
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab
Articolo
Tumor chemosensitization by physical exercise? Insights from an anidmal model
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
